MedPath
NMPA Approval

Ivabradine Hydrochloride Tablets

国药准字HJ20150273

May 31, 2024

H20150273

Drug Information

盐酸伊伐布雷定片

可兰特

片剂

5mg

化学药品

May 31, 2024

May 30, 2029

Company Information

Applicant Company

50, rue Carnot, 92284 Suresnes cedex

Manufacturing Company

905 route de Saran, F-45520 Gidy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸伊伐布雷定片 - NMPA 批准文号 | MedPath